A study demonstrated that cordycepin synergizes with CTLA-4 suppressant to alter the responsive and depletion condition of CD8T cells, thus enhancing CD8 T cell-mediated tumor microenvironment (TME) anti-tumor immunity, remodeling the tumor microenvironment, and enhancing cancer immunotherapy (16). The gene discussed is CD8A; the disease is neoplasm.